diabetes drugs

ONGLYZA ® - Saxagliptin

ONGLYZA ® a drug based on Saxagliptin THERAPEUTIC GROUP: Oral hypoglycemic agents - DPP-4 inhibitors IndicationsAction mechanismStudies and clinical effectiveness Usage and dosage instructionsWarnings Pregnancy and lactationInteractionsContraindicationsUndesirable effects Indications ONGLYZA ® - Saxagliptin ONGLYZA ® is used as a pharmacological aid for the second type of diabetic pathology, in addition to metformin, sulfonylureas and agonists of PPAR gamma, when single therapies have not produced the desired therapeutic effect. M

diabetes drugs

Comtan - entacapone

2019

What is Comtan? Comtan is a drug containing the active substance entacapone, available in orange-brown tablets (200 mg). What is Comtan used for? Comtan is indicated for the treatment of patients with Parkinson's disease. Parkinson's disease is a progressive mental disorder that causes tremor, slowness of movement and muscle stiffness

diabetes drugs

DAONIL ® - Glibenclamide

2019

DAONIL ® is a drug based on Glibenclamide THERAPEUTIC GROUP: Oral hypoglycemic agents - Sulfonylureas IndicationsAction mechanismStudies and clinical effectiveness Usage and dosage instructionsWarnings Pregnancy and lactationInteractionsContraindicationsUndesirable effects Indications DAONIL ® - Glibenclamide DAONIL ® is indicated as a pharmacological aid in the treatment of type II diabetes mellitus, in the event of failure of non-pharmacological therapeutic measures such as a balanced diet and a healthy lifestyle. M

diabetes drugs

DIABREZIDE ® - Gliclazide

2019

DIABREZIDE ® a Gliclazide based drug. THERAPEUTIC GROUP: Oral hypoglycemic agents - Sulfonylureas IndicationsAction mechanismStudies and clinical effectiveness Usage and dosage instructionsWarnings Pregnancy and lactationInteractionsContraindicationsUndesirable effects Indications DIABREZIDE ® - Gliclazide DIABREZIDE ® is indicated as a pharmacological treatment of type II diabetes, in combination with adequate nutrition and a healthy lifestyle. T

diabetes drugs

DIAMICRON ® - Gliclazide

2019

DIAMICRON ® a Gliclazide based drug. THERAPEUTIC GROUP: Oral hypoglycemic agents - Sulfonylureas IndicationsAction mechanismStudies and clinical effectiveness Usage and dosage instructionsWarnings Pregnancy and lactationInteractionsContraindicationsUndesirable effects Directions DIAMICRON ® - Gliclazide DIAMICRON ® is used in the treatment of hyperglycemia in patients with type II diabetes, not adequately compensated by non-pharmacological measures such as physical activity and healthy eating. M

diabetes drugs

Efficib - sitagliptin and metformin hydrochloride

2019

What is Efficib? Efficib is a medicine containing two active substances, sitagliptin and metformin hydrochloride. it is available in capsule-shaped tablets (pink: 50 mg of sitagliptin and 850 mg of metformin hydrochloride; red: 50 mg of sitagliptin and 1, 000 mg of metformin hydrochloride). What is Efficib used for

diabetes drugs

Enyglid - repaglinide

2019

What is Enyglid? Enyglid is a medicine that contains the active substance repaglinide, available as round tablets (white: 0.5 mg; yellow: 1 mg; pink: 2 mg). Enyglid is a generic medicine, which means that it is similar to a "reference medicine" already authorized in the European Union (EU) called NovoNorm

diabetes drugs

Eperzan - albiglutide

2019

What is Eperzan - albiglutide and what is it used for? Eperzan is a diabetes medicine containing the active substance albiglutide . It is indicated in adult patients with type 2 diabetes mellitus to improve blood glucose (sugar) control. Eperzan can be used as the only therapy when diet and exercise alone do not provide adequate control of blood glucose levels in patients who cannot take metformin (another antidiabetic medicine)

diabetes drugs

Eucreas - vildagliptin and metformin hydrochloride

2019

What is Eucreas? Eucreas is a drug containing the active substances vildagliptin and metformin hydrochloride. It is available as oval tablets (dark yellow: 50 mg / 850 mg; light yellow: 50 mg / 1 000 mg). What is Eucreas used for? Eucreas is used to treat type 2 diabetes (non-insulin-dependent diabetes)

diabetes drugs

EUGLUCON ® - Glibenclamide

2019

EUGLUCON ® is a drug based on Glibenclamide THERAPEUTIC GROUP: Oral hypoglycemic agents - Sulfonylureas IndicationsAction mechanismStudies and clinical effectiveness Usage and dosage instructionsWarnings Pregnancy and lactationInteractionsContraindicationsUndesirable effects Indications EUGLUCON ® - Glibenclamide EUGLUCON ® is a drug indicated for the treatment of type II diabetes mellitus in the absence of satisfactory results obtained by non-pharmacological therapies. E

diabetes drugs

Forxiga

2019

What is Forxiga? Forxiga is a medicine that contains the active substance dapagliflozin. It is available as tablets (5 and 10 mg). What is Forxiga used for? Forxiga is used to treat adults with type 2 diabetes. Forxiga can be used on its own (monotherapy) when diet and exercise alone do not provide adequate control of glucose (sugar) levels in the blood in patients intolerant of metformin (another antidiabetic medicine)